Please click here to visit our sponsor

Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


ww1 army records 468x60



Western Medicine VS. Traditional Afrikan Medicine
AllAfrica.com, Washington - 10 hours ago
Their diet was their medicine. Indeed when they did fall ill, they used natural traditional remedies in accordance with biblical teachings as outlined in ...


Times Online

The latest trend in medicine - virtual reality
Times Online, UK - 9 hours ago
Imagine the scenario: you're sitting on a plane, strapped in and ready for take-off. But you're terrified of flying and are suddenly hit by an ...


GCC Ministers to Tackle Alternative Medicine Issue in Geneva Confab
Arab News, Saudi Arabia - May 15, 2008
JEDDAH, 16 May 2008 — In spite of advertisements about herbal and natural cures for health problems being common on Arabic television, alternative medicine ...


Many children using unsafe, ineffective medicine: expert
ABC Online, Australia - May 15, 2008
... that make the drug, so it's the sponsor of the medicine that decides whether they will or won't apply for marketing approval of that medicine," she said.


BMJ Group Teams up with the College of Emergency Medicine
eHealthNews.EU (press release), Germany - 4 hours ago
BMJ Learning, part of the BMJ Group, announced that it has formed a partnership with the College of Emergency Medicine in the UK, to provide Continuous ...


Poor medicine for poor people
Globe and Mail, Canada - May 15, 2008
New field research shows that a third of anti-malaria drugs collected in six African cities fail at least one quality test, and aid agencies continue to ...


Ecological medicine
Schenectady Gazette, NY - 9 hours ago
Here, lines of people waited for free foot reflexology, Reiki, energy medicine, and massage. Folks learned about mindfulness meditation, and acupuncture for ...


Elvis Presley medicine bottle up for auction
The Post, Pakistan - 7 hours ago
An empty medicine bottle belonging to Elvis Presley is to go under the hammer later this month. A toaster owned by Sir Elton John and a Christmas card from ...


Police: Missing Butler Man's Diabetes Medicine Found At Home
Pittsburgh Channel.com, PA - 10 hours ago
Police said he needs medicine for his diabetes, but his treatments were found at his Grant Avenue home. Anyone with information is asked to contact police.


Faith medicine proves fatal
Independent Online, South Africa - May 15, 2008
Two women, aged 27 and 38, died and six others fell ill after allegedly receiving medicine from a faith mission in Komga near Cambridge, Eastern Cape police ...

Medicine - Google News

home | site map

© 2006 www.elearn-university.org